N6-[3-(propan-2-yloxy)propyl]-9H-purine-2,6-diamine



Compound IDCDAMM00092
Common nameN6-[3-(propan-2-yloxy)propyl]-9H-purine-2,6-diamine
IUPAC name6-N-(3-propan-2-yloxypropyl)-7H-purine-2,6-diamine
Molecular formulaC11H18N6O

Experimental data

Retention time44.2
Adduct[M+H]+
Actual mz251.162
Theoretical mz251.161
Error2.46
Ionizaton modePositive
Instrument typeLC-MS/MS-QTOF, spectrum predicted by MS-DIAL v4.9 integrated with MS-FINDER 3.60
Score4.3459

Identifiers and class information

Inchi keyNXFBEILCNHEDSO-UHFFFAOYSA-N
SmilesCC(C)OCCCNC1=NC(=NC2=C1NC=N2)N
SuperclassOrganoheterocyclic compounds
ClassImidazopyrimidines

Pharmacokinetic properties

Number of descriptor values(#stars)0
Number of non-conjugated amine groups (#amine)0
Number of amidine and guanidine groups (#amidine)0
Number of carboxylic acid groups (#acid)0
Number of non-conjugated amide groups (#amide)0
Number of rotatable bonds (#rotor)7
Number of reactive functional groups (#rtvFG)0
Predicted central nervous system activity (CNS)-2
Molecular weight (mol_MW)250.303
Computed dipole moment(dipole)8.188
Total solvent accessible surface area (SASA)532.721
Hydrophobic component of SASA (FOSA)279.942
Hydrophilic component of SASA (FISA)163.204
Pie component of the SASA (PISA)89.575
Weakly polar component of the SASA (WPSA)0
Total solvent accesible volume (volume)884.406
Number of hydrogen bond donors (donorHB)4
Number of hydrogen bond acceptors (accptHB)6.2
Free energy of solvation of dipole (dip^2/V)0.0758036
Index of cohesive interaction in solids (ACxDN^.5/SA)0.0232767
Globularity descriptor (glob)0.836436
Predicted polarizability in cubic angstroms (QPpolrz)25.601
Predicted hexadecane/gas partition coefficient (QPlogPC16)9.002
Predicted octanol/gas partition coefficient (QPlogPoct)18.138
Predicted water/gas partition coefficient (QPlogPw)13.142
Predicted octanol/water partition coefficient (QPlogPo/w)0.854
Predicted aqueous solubility (QPlogS)-2.647
Conformation-independent predicted aqueous solubility (CIQPlogS)-2.444
Predicted IC50 value for blockage of HERG K+ channels (QPlogHERG)-4.606
Predicted apparent Caco-2 cell permeability in nm/sec (QPPCaco)280.694
Predicted brain/blood partition coefficient (QPlogBB)-1.414
Predicted apparent MDCK cell permeability in nm/sec (QPPMDCK)125.301
Predicted skin permeability, log Kp (QPlogKp)-3.54
PM3 calculated ionization potential (IP(ev))7.963
PM3 calculated electron affinity (EA(eV))0.147
Number of likely metabolic reactions (#metab)2
Prediction of binding to human serum albumin (QPlogKhsa)-0.5
Predicted qualitative human oral absorption (HumanOralAbsorption)3
Predicted human oral absorption on 0 to 100% scale (PercentHumanOralAbsorption)75.764
Solvent-accessible surface area of fluorine atoms (SAFluorine)0
Solvent-accessible surface area of amide oxygen atoms (SAamideO)0
Van der Waals surface area (PSA)96.891
Number of nitrogen and oxygen atoms (#NandO)7
Number of violations of Lipinski’s rule of five (RuleOfFive)0
Number of violations of Jorgensen’s rule of three (RuleOfThree)0

Compound-target network

Cytoscape Graph

Protein targets associated with phytocompound

Uniprot ID Gene name Target name TTD_ID Prediction source
Q9Y2T3GDAGuanine deaminaseT92460SEA
P16455MGMT6-O-methylguanine-DNA methyltransferaseT24587SEA
Q9NR97TLR8Toll-like receptor 8T48703SEA
Q9NYK1TLR7Toll-like receptor (TLR7/TLR9)T46482SEA

Target associated diseases

TTD_ID Disease_ID Disease name ICD_11 Uniprot ID Gene names
T24587DI0369Sarcoma[ICD-11: 2A60-2C35]P16455MGMT
T48703DI0133Epidermal dysplasias[ICD-11: EK90]Q9NR97TLR8
T48703DI0179Hepatitis virus infection[ICD-11: 1E50-1E51]Q9NR97TLR8
T48703DI0180Herpes simplex infection[ICD-11: 1F00]Q9NR97TLR8
T48703DI0239Lupus erythematosus[ICD-11: 4A40]Q9NR97TLR8
T48703DI0252Melanoma[ICD-11: 2C30]Q9NR97TLR8
T48703DI0283Mycosis fungoides[ICD-11: 2B01]Q9NR97TLR8
T48703DI0391Solid tumour/cancer[ICD-11: 2A00-2F9Z]Q9NR97TLR8
T48703DI0393Squamous cell carcinoma[ICD-11: 2B60-2D01]Q9NR97TLR8
T48703DI0432Vasomotor/allergic rhinitis[ICD-11: CA08]Q9NR97TLR8
T46482DI0243Malaria[ICD-11: 1F40-1F45]Q9NYK1TLR7
T46482DI0384Skin disease[ICD-11: EA00-EM0Z]Q9NYK1TLR7

Copyright © 2025